You are here

  • Home
  • Archive
  • Volume 105, Issue 4
  • Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study

Article metrics

Article menu
Download PDFPDF
Clinical science
Cardiovascular risk in patients receiving ranibizumab for exudative age-related macular degeneration: a nationwide self-controlled case-series study

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 20201746867845
Jul 20201893991976
Aug 2020196165
Sep 2020212100
Oct 202018171
Nov 202019000
Dec 202019521
Jan 202114813
Feb 20212261711
Mar 20215802420
Apr 20216223124
May 2021166125
Jun 2021221612
Jul 2021181112
Aug 2021201912
Sep 20211265
Oct 202111097
Nov 20219282
Dec 20219394
Jan 2022134173
Feb 20225822
Mar 202278105
Apr 20226434
May 2022189115
Jun 20229283
Jul 202282113
Aug 20229842
Sep 202210134
Oct 20227121
Nov 20224231
Dec 20221200
Jan 20233455
Feb 202310680
Mar 20234741
Apr 20234540
May 20232100
Jun 20235363
Jul 20233600
Aug 20232031
Sep 202313234
Oct 20236521
Nov 20234842
Dec 20234322
Jan 202476210
Feb 20245203
Mar 202429127
Total855021852017